Follow-Up for Soft Tissue Sarcoma

"This medical trial's primary outcome is to measure the mean area under the curve of the Fear of Cancer Recurrence Inventory - Short Form over a time frame ranging from baseline to 12 months post-surgery. Additionally, secondary outcomes are being monitored such as time to local recurrence (Kaplan-Meier method), degree of change in anxiety and depression (Hospital Anxiety and Depression Scale) along with out-of-pocket expenditures incurred by patients (Cost Survey). All these factors will be compared between two low risk groups whilst taking into account age, gender, and other relevant patient prognostic variables." - Anonymous Online Contributor

"Taking into account the fact that this is Phase 2 clinical trial with only some evidence of safety, but no proof of efficacy, our team at Power gave Follow-Up a score of 2 on their scale from 1 to 3." - Anonymous Online Contributor

"Affirmative. Clinicaltrials.gov data indicates that this medical experiment, originally posted on December 28th 2020, is actively looking for enrollees. Specifically, 227 patients need to be collected from 1 specific site." - Anonymous Online Contributor

"Per information on clinicaltrials.gov, this trial is actively enrolling patients. It was initially posted to the database on December 28th 2020 and last amended on September 28th 2022." - Anonymous Online Contributor